Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
Clinical trial NCT05912621 · RECRUITING
Trial details
- NCT number
- NCT05912621
- Sponsor
- Stanford University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2028-06-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.